rss
J Med Genet 2006;43:829-832 doi:10.1136/jmg.2005.040329
  • Letters to JMG

Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene

  1. R H Lekanne Deprez1,*,
  2. J J Muurling-Vlietman2,*,
  3. J Hruda3,
  4. M J H Baars4,
  5. L C D Wijnaendts5,
  6. I Stolte-Dijkstra6,
  7. M Alders1,
  8. J M van Hagen4
  1. 1Department of Clinical Genetics, AMC, Amsterdam, Netherlands
  2. 2Department of Paediatrics, VU University Medical Centre, Amsterdam
  3. 3Department of Paediatric Cardiology, VU University Medical Centre, Amsterdam
  4. 4Department of Clinical and Human Genetics, VU University Medical Centre, Amsterdam
  5. 5Department of Pathology, VU University Medical Centre, Amsterdam
  6. 6Department of Clinical Genetics, University Medical Centre Groningen, University of Groningen, Netherlands
  1. Correspondence to:
 Dr Ronald H Lekanne dit Deprez
 Department of Clinical Genetics, AMC Hospital, Room T0-315, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands; R.H.Lekanne{at}amc.uva.nl
  • Received 22 December 2005
  • Accepted 10 April 2006
  • Revised 6 April 2006
  • Published Online First 5 May 2006

Abstract

Background: Idiopathic (primary) hypertrophic cardiomyopathy (HCM) is mainly caused by mutations in genes encoding sarcomeric proteins. One of the most commonly mutated HCM genes is the myosin binding protein C (MYBPC3) gene. Mutations in this gene lead mainly to truncation of the protein which gives rise to a relatively mild phenotype. Pure HCM in neonates is rare and most of the time childhood HCM occurs in association with another underlying condition.

Objective: To study the presence of mutations in the MYBPC3 gene in idiopathic childhood HCM.

Methods:MYBPC3 coding region and splice junction variation were analysed by denaturing high performance liquid chromatography (DHPLC) and sequencing in DNA isolated from two neonates with severe unexplained HCM, who died within the first weeks of life.

Results: Truncating mutations were found in both alleles of the MYBPC3 gene in both patients, suggesting there was no functional copy of the MYBPC3 protein. Patient 1 carried the maternally inherited c.2373_2374insG mutation and the paternally inherited splice-donor site mutation c.1624+1G→A. Patient 2 carried the maternally inherited frameshift mutation c.3288delA (p.Glu1096fsX92) and the paternally inherited non-sense mutation c.2827C→T (p.Arg943X).

Conclusions: The findings indicate the need for mutation analysis of genes encoding sarcomeric proteins in childhood HCM and the possibility of compound heterozygosity.

Footnotes

  • Published Online First 5 May 2006

  • ↵* These authors made an equal contribution to the work.

  • Conflict of interest: none declared

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jmg.2005.040329v1
    2. 43/10/829 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.